Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a rand...

by Hassan B. Awal, Seshagiri Rao Nandula, Cleyton C. Domingues, Fiona J. Dore, Nabanita Kundu, Beda Brichacek, Mona Fakhri, Adrian Elzarki, Neeki Ahmadi, Shauna Safai, Magan Fosso, Richard L. Amdur, Sabyasachi Sen
Published 2020-06-01